News
News
- Kura Oncology Reports Clinical and Regulatory Updates for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma
12/08/2019 / 18:00 - GlobeNewswire - Fate Therapeutics Announces New Preclinical Data for FT596 Off-the-Shelf, iPSC-derived CAR NK Cell Cancer Immunotherapy
12/08/2019 / 16:39 - GlobeNewswire - Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual Meeting
12/07/2019 / 15:00 - GlobeNewswire - Fate Therapeutics Announces Clinical Data from Landmark Phase 1 Studies of First-ever Universal, Off-the-shelf, iPSC-derived NK Cell Cancer Immunotherapy Programs
12/07/2019 / 14:40 - GlobeNewswire - INNATE PHARMA RELEASES ITS FINANCIAL CALENDAR FOR 2020
12/04/2019 / 07:00 - GlobeNewswire - INmune Bio, Inc. Announces First Alzheimer’s Disease Patient Dosed in XPro1595 Study
12/02/2019 / 15:00 - GlobeNewswire - Fate Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
11/27/2019 / 22:01 - GlobeNewswire - Menlo Therapeutics CEO to Participate in Fireside Chat at the Piper Jaffray 31st Annual Healthcare Conference
11/27/2019 / 14:00 - GlobeNewswire - INmune Bio Inc. to Discuss Potential New Alzheimer’s Disease Treatments in CTAD Pre-Conference Webinar
11/26/2019 / 12:00 - GlobeNewswire - Equinor ASA: Announcement of dividend per share for the second quarter 2019 in NOK
11/25/2019 / 07:45 - GlobeNewswire
Real-time